Celcuity, Inc. (CELC)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$64.04-7.51%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · CELC
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | ||||||||||
| R&D Expenses | 143.0 | 145.0 | 104.2 | 60.6 | 35.3 | 25.8 | 7.7 | 6.3 | 6.3 | 5.0 |
| Operating Income | (208.7) | (172.2) | (113.3) | (66.2) | (39.4) | (28.4) | (9.6) | (7.8) | (7.9) | (6.0) |
| Earnings from Continuing Operations | ||||||||||
| Interest Expense | — | 17.1 | 10.3 | 5.3 | 2.1 | 1.3 | 0.0 | 0.0 | 0.0 | 0.5 |
| Interest & Investment Income | 15.9 | 12.3 | 11.8 | 7.8 | 1.1 | 0.0 | 0.1 | 0.4 | 0.4 | 0.2 |
| Net Interest Expenses | — | — | — | (2.5) | 1.0 | 1.2 | (0.1) | (0.4) | (0.4) | 0.3 |
| Other Non-Operating Income / Expenses | (17.8) | (4.9) | 1.5 | 2.5 | — | — | 0.1 | 0.4 | 0.5 | (0.3) |
| EBT, Incl. Unusual Items | (226.5) | (177.0) | (111.8) | (63.8) | (40.4) | (29.6) | (9.5) | (7.4) | (7.5) | (6.3) |
| Income Tax Expense | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | ||||||||||
| Net Income | (226.5) | (177.0) | (111.8) | (63.8) | (40.4) | (29.6) | (9.5) | (7.4) | (7.5) | (6.3) |
| Per Share | ||||||||||
| Basic EPS | (4.13) | (3.79) | (2.83) | (2.69) | (2.64) | (2.21) | — | — | — | — |
| Diluted EPS | (4.13) | (3.79) | (2.83) | (2.69) | (2.64) | — | — | — | — | — |
| Basic Weighted Avg Shares | 54.8 | 46.8 | 39.4 | 23.7 | 15.4 | 13.4 | — | — | — | — |
| Diluted Weighted Avg Shares | 54.8 | 46.8 | 39.4 | 23.7 | 15.4 | — | — | — | — | — |
| Supplemental | ||||||||||
| EBIT | (208.7) | (172.2) | (113.3) | (66.2) | (39.4) | (28.4) | (9.6) | (7.8) | (7.9) | (6.0) |
| Effective Tax Rate | — | — | — | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.